SMITH SEAN MICHAEL (Principal Accounting Officer) sold 5.8% of their position (1.32K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $818.14 — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/14/2023ACC: 0001209191-23-045611
Officer· Principal Accounting Officer
Since Mar 2022
-1.32K
Net shares
Net seller
$818.14
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 6.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
27.8%
8/10/2023
17.96K→22.96K
Common Stock
Direct
Shares
−1.32K
Price / share
$0.62
Trade value
$818.14
% of position
5.8%
8/11/2023
22.96K→21.64K
Total
Net shares
+3.68K
Net value
-$818.14
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2023 | M · Option Exercise | +5K | — | — | 27.8% | 17.96K | 22.96K |
| Common Stock Direct | 8/11/2023 | S · Sale | −1.32K | $0.62 | $818.14 | 5.8% | 22.96K | 21.64K |
| Total | +3.68K | -$818.14 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
0.00
Held after
0.00
Exercisable
—
8/10/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5K shares | 8/10/2023 | M · Option Exercise | −5K | 0.00 | — | 0.00 |